This is a pilot 12-week randomized, placebo-controlled N-of-1 deprescribing trial among older men receiving chronic tamsulosin therapy for lower urinary tract symptoms attributed to benign prostatic hyperplasia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Adapted International Prostate Symptom Score (IPSS)
Timeframe: Every day for 12 weeks. Daily adapted IPSS scores will be averaged over the treatment period.